6-Formylpterin (6FP, Fig. 1 ) is known as a potent xanthine oxidase inhibitor with an inhibition constant (K i ) of approximately 0.6 nM.
1,2) Although 6FP does not usually occur in vivo, it is produced from folic acid in vivo in some pathological conditions, such as carcinoma. 3) In previous studies, we showed that 6FP suppressed release of superoxide anion (O 2 · Ϫ ) from activated human neutrophils by chemiluminescence using an O 2 · Ϫ -specific probe, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (CLA), 4) and that 6FP attenuated neuronal damage in global brain ischemia in gerbils. 5) From these findings, we speculated that 6FP exerted the neuroprotective effects by its O 2 · Ϫ scavenging activity. Afterwards, however, it was shown that 6FP had light absorbance at around 380 nm. 6) In chemiluminescence, the reaction of O 2 · Ϫ with CLA emits light output at 380 nm.
7)
Therefore, it is now difficult to tell whether 6FP suppressed release of O 2 · Ϫ from activated neutrophils or it merely suppressed light output of O 2 · Ϫ , so it is questionable if 6FP has O 2 · Ϫ scavenging activity or not. Thus, we must consider another mechanism for the neuroprotective effects of 6FP other than O 2 · Ϫ scavenging activity. Not only O 2 · Ϫ but also other reactive oxygen species (ROS), such as hydrogen peroxide (H 2 O 2 ) and hydroxyl radicals (· OH) are involved in neuronal damage. 8) Recently, in addition to these ROS, singlet oxygen ( 1 O 2 ) has become known as an effector of neuronal damage.
9)
Meanwhile, 6FP and other commercially available pterin derivatives, pterin (Pn), pterin-6-carboxylic acid (P6COOH), neopterin (NP) and biopterin (BP) were shown to have quenching ability of 1 O 2 in a cell-free system. 10) In the present study, in order to confirm the 1 O 2 scaveng- 
MATERIALS AND METHODS
Reagents 6FP was obtained from Sankyo Kasei Kogyo (Hiratsuka, Japan). Pn, P6COOH, NP and BP were purchased from Sigma Chemicals (St. Louis, MO, U.S.A.). 6FP and other pterin derivatives were initially dissolved in saline with 0.1 N NaOH to make a 30 mM solution, then diluted with phosphate-buffered saline (PBS) to a final concentration of 4 mM (pHϭ8.0). Novel pterin derivatives (Fig. 1) , 2-amino-6-formyl-3-methylpteridin-4-one (FM), 2-(N,N-dimethylaminomethyleneamino)-6-formyl-3-methylpteridin-4-one (DFM) and 2-(N,N-dimethylaminomethyleneamino)-6-formyl-3-pivaloylpteridin-4-one (DFP), were synthesized in our laboratories as previously described.
11) Novel pterin de- 
.).
Chemiluminescence Human neutrophils were isolated from peripheral blood of healthy adult volunteers by sedimentation through two-step Percoll (Pharmacia, Uppsala, Sweden) gradients. Healthy adult volunteers provided written informed consent for participation in an institutional review board-approved protocol at Kyoto University Hospital. Freshly purified cells were cultured in HBSS and kept on ice until use. Zymosan was first activated by boiling, and then the activated zymosan was incubated and reacted with fresh AB human serum. The zymosan was resuspended in HBSS and used as opsonized zymosan (OZ). The 1 O 2 scavenging activities of 6FP and other pterin derivatives were examined by chemiluminescence using a 1 O 2 specific probe, MVP.
12)
After mixing the neutrophils (2ϫ10 6 cells) and 40 mM MVP with the appropriate concentrations of pterin derivatives in HBSS, the mixture was mounted on a luminescence reader (Aloka BLR-301) and the luminescence was monitored every 10 s for 10 min. The OZ (1 mg/ml) was added to the mixture 30 s after the measurement was started. 
RESULTS AND DISCUSSION
When the neutrophils were activated with OZ, 1 O 2 was released from neutrophils. 6FP, Pn, P6COOH, NP and BP suppressed the OZ-induced 1 O 2 release, and their extent of suppression was almost equal at the concentration of 400 mM (Fig. 2) . This result agreed with the finding that Thomas et al. showed in cell-free system. 10) On the other hand, novel pterin derivatives, FM, DFM and DFP, suppressed the OZinduced 1 O 2 release in a dose-dependent manner, and their extent of suppression was more potent than that of 6FP. The inhibitory effects of novel pterin derivatives on 1 O 2 release from activated neutrophils were enhanced according to the following order; 6FP, FM, DFM and DFP (Fig. 3) . O 2 was generated and the emission spectrum of 1 O 2 was clearly observed using Raman spectroscopy (Fig. 4,  Control) . 6FP suppressed the emission spectrum of 1 O 2 , and novel pterin derivatives suppressed the spectrum more potently than 6FP, according to the following order; 6FP, FM, DFM and DFP (Fig. 4) . This result showed that novel pterin derivatives certainly had direct scavenging activity of with the same order of potency which was shown in biological assay.
The total rate constant of 1 O 2 quenching (k t ) by pterin derivatives (P) consisted of rate constant of the chemical reaction of 1 O 2 with pterin derivatives (k r ) and that of the 1 O 2 physical quenching by pterin derivatives (k q ) (k t ϭk r ϩk q ). 15, 16) In our result, there was no difference in 1 O 2 scavenging activity among 6FP, Pn, P6COOH, NP and BP, despite different substitutions at the 6-position (Fig. 1, the Ϫ1 is an order of magnitude larger than k r ). 15) This indicated that the chemical reaction did not play a major role in 6FP, P6COOH, NP and BP as well as Pn, which is possibly the reason why there was no difference in 1 O 2 scavenging activity among 6FP, Pn, P6COOH, NP and BP.
In our result, there were distinct differences in 1 O 2 scavenging activity among 6FP, FM, DFM and DFP. Since the structure of the 6-position is the same in 6FP, FM, DFM, and DFP (Fig. 1 , the column of R 6 ), the difference of the substitutions at the 2-and/or 3-position affected the potency of 1 O 2 scavenging activity. It was reported that 1 O 2 is deactivated by the reaction with the pyrazinic or dihydropyrazinic ring of 6-position substituted pterin derivatives. 15, 17) There is a possibility that the pyrazinic ring of 6FP has 1 O 2 quenching activity. So, we focused on the modification of the 2-and 3-position of 6FP. As for the substitution at the 2-position, hydrogen atoms on the 2-position of 6FP and FM are replaced by N,N-dimethylaminomethylene in DFM and DFP (Fig. 1 , the column of R 2 ). It was reported that amines quench 1 O 2 by the means of physical quenching (k q ).
18) The 1 O 2 physical quenching mechanism involves the process of charge-transfer from N-lone electron pair of amine to O 2 , and the 1 O 2 quenching efficiency of tertiary amines are larger than primary amines because of its low ionization potentials. 18, 19) Therefore, it is possible that N,N-dimethylaminomethylene group of DFM and DFP contributes to increase k q compared to amido group of 6FP and FM. This may be the reason why the 1 O 2 scavenging activities of DFM and DFP were more potent than those of 6FP and FM. As for the substitution at the 3-position, a hydrogen atom on the 3-position of 6FP is replaced by methyl group in FM (Fig. 1, the column of R 3 ), and the 1 O 2 scavenging activity of FM was more potent than that of 6FP in which the 3-position is free. Further, a hydrogen atom on the 3-position of 6FP is replaced by the pivaloyl group in DFP, and the 1 O 2 scavenging activity of DFP was more potent than that of DFM in which the 3-position is replaced by methyl group. These results indicated that modification of the 3-position also contributes to 1 O 2 physical quenching.
In conclusion, the substitutions at the 2-and/or 3-position play an important role in 1 O 2 scavenging activity of pterin derivatives. For several years, growing interest has been given to the role of 1 O 2 in pathological situations and particularly in the oxidative stress induced by postischemic reperfusion. 20) The neuroprotective effects of 6FP shown in experimental brain ischemia in our previous study 5) might be also attributed to its 1 O 2 scavenging activity. On the basis of the findings of this study, more potent 1 O 2 scavengers should be developed, which may serve as more potent neuroprotective agents.
